Trial intelligence / Profile preview

Nowarta110 in Plantar Warts

NCT02338336Phase 2Completed

Sponsor
Nowarta Biopharma Inc.
Start
Feb 2015
Primary completion
Sep 2015
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Nowarta110 in plantar wart, sponsored by Nowarta Biopharma Inc.. Started Feb 2015; status: completed.

02

Drugs

Nowarta110
03

Conditions

plantar wart

Beyond the preview

Go deeper on NCT02338336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02338336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call